small-cap

Pureprofile’s acquisition move on the cards

Sep 21, 2016 | Team Kalkine
Pureprofile’s acquisition move on the cards


 
The online advertising analytics company, Pureprofile Limited (ASX: PPL), has been placed in a trading halt session state until September 22, 2016, pending a company announcement. PPL is making efforts to raise about $14 million in an institutional placement and another $3 million via a share purchase plan (SPP). This is expected to be used for funding the acquisition of Cohort Group owned by Oceania Capital Partners. This acquisition is said to be worth $18 million with $15 million upfront payment and $3 million in Pureprofile shares, and is said to bring synergy considering complementarity to PPL’s business. The issue price (45 cents a share) has been said to be at a discount of 13.5% to the last traded price and at a 15.6% discount to the 15-day volume weighted average price. The bids for the offer, open to sophisticated and professional investors, were to be received no later than 12 PM (AEST) Wednesday, September 21, 2016.
 

PPL’s Growth Strategy (Source: Company Reports)
 
PPL otherwise reported for a strong start to FY2017 with Q1 revenue expected to grow over $8m. The company also expects its international revenue growth to deliver more than 50% of the group’s revenue in FY2017. Further, Q1 revenue is reported to be up 27% compared to Q1FY2016 and 11% up against Q4FY2016. The company further highlighted that there has been 31% year-on-year growth for its Data & Insights division while 200% year-on-year growth was noted for Adsparc publisher yield optimisation business. Operations in Europe and US continue to be growing stronger.



Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Past performance is not a reliable indicator of future performance.